Cannabis Use and Outcomes in Black and White Patients With Cancer

Part of paid clinical trials in Buffalo, New York.

Sponsor
State University of New York at Buffalo
Study ID
NCT06037681
Status
Recruiting

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
21 Years - 99 Years
Healthy Volunteers
Not accepted

Study Details

The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.

Key Dates

Start date
Mar 30, 2023
Status verified
Oct 2025
Primary completion
Sep 30, 2026
Completion
Mar 30, 2027

Study Design

Enrollment
600 participants (estimated)

Arms

  • Arm: Black cannabis users
    African Americans that use cannabis at least once a week
  • Arm: Black non-cannabis users
    African Americans that do not use cannabis for at least 3 months prior to enrollment
  • Arm: White cannabis users
    Caucasians that use cannabis at least once a week
  • Arm: White non-cannabis users
    Caucasians that do not use cannabis for at least 3 month prior to enrollment

Primary Outcome Measure

Change from baseline of Cannabis use [ Time Frame: Baseline to 12 months ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University at BuffaloBuffaloNew York14214
Colleen Kilanowski, MS
716-829-5977
Rebecca Ashare, PhD
716-829-2024
Thomas Jefferson UniversityPhiladelphiaPennsylvania19144
Brooke Worster, MD
Brooke.Worster <[email protected]>
215-955-1888
Amy Leader, MPH
215-955-7739
University of PennsylvaniaPhiladelphiaPennsylvania19176
Andy Robinson
215-746-7335
Salimah Meghani, PhD
512-573-7128

Find similar trials in Buffalo, NY

Related Studies